| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4863641
Max Phase: Preclinical
Molecular Formula: C28H47NO2
Molecular Weight: 429.69
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](C)NC(=O)c1ccc(C(C)(C)C)cc1
Standard InChI: InChI=1S/C28H47NO2/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-26(30)23(2)29-27(31)24-19-21-25(22-20-24)28(3,4)5/h17-23,26,30H,6-16H2,1-5H3,(H,29,31)/b18-17+/t23-,26-/m1/s1
Standard InChI Key: TYEYAOPOKFHELS-QGQLGBQUSA-N
Associated Targets(Human)
Neutral ceramidase 95 Activities
Acid ceramidase 411 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 429.69 | Molecular Weight (Monoisotopic): 429.3607 | AlogP: 7.33 | #Rotatable Bonds: 15 |
| Polar Surface Area: 49.33 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 8.39 | CX LogD: 8.39 |
| Aromatic Rings: 1 | Heavy Atoms: 31 | QED Weighted: 0.23 | Np Likeness Score: 0.14 |
References
| 1. Bielsa N, Casasampere M, Aseeri M, Casas J, Delgado A, Abad JL, Fabriàs G.. (2021) Discovery of deoxyceramide analogs as highly selective ACER3 inhibitors in live cells., 216 [PMID:33677352] [10.1016/j.ejmech.2021.113296] |
Source
Source(1):